EMD Millipore Muse™ Cell Analyzer Wins Prestigious GOOD DESIGN® Award

  EMD Millipore Muse™ Cell Analyzer Wins Prestigious GOOD DESIGN® Award

  *Muse™ Cell Analyzer Recognized by The Chicago Athenaeum: Museum of
    Architecture and Design

Business Wire

BILLERICA, Mass. -- February 28, 2013

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany,
has received the Good Design 2012 award for its product the Muse™ Cell
Analyzer. The Chicago Athenaeum: Museum of Architecture and Design and
Metropolitan Arts Press Ltd. present the Museum's annual GOOD DESIGN® Awards
Program for the most innovative and cutting-edge industrial, product, and
graphic designs produced around the world. Founded in Chicago in 1950, GOOD
DESIGN® is one of the oldest and the world’s most recognized program for
design excellence worldwide.

EMD Millipore Muse(TM) Cell Analyzer (Photo: Business Wire)

EMD Millipore Muse(TM) Cell Analyzer (Photo: Business Wire)

The Muse™ Cell Analyzer system, which was launched in 2012, delivers real-time
quantitative assessment of cell health, apoptosis, protein phosphorylation,
cell cycle and immunophenotype with greater accuracy and precision than manual
hemocytometry or image-based automated analysis. The GOOD DESIGN® jury
recognized Muse™ Cell Analyzer for its high design quality within the medical
product category.

“It is an honor to be recognized for the innovative design of the Muse™ Cell
Analyzer,” said John Sweeney, Head of Life Sciences business at EMD Millipore.
"We set out to produce a flow cytometer that was optimally designed in how
scientists would use the instrument within the confines of available lab
space-- without comprising on performance and data quality. It is pleasing to
see that external organizations, as well as customers, acknowledge this."

By providing real-time, multi-dimensional information on cell populations, the
Muse™ Cell Analyzer enables faster, more accurate decision-making, more
productive workflows, and greater insight into cell health.

The Muse™ system also delivers high-performance cell analysis using
patent-pending, miniaturized fluorescent detection and microcapillary
technology which occupy one-tenth the space of a typical cytometer.
Laser-based fluorescence detection of each cell event can evaluate up to three
cellular parameters. As a result, the Muse™ system provides accurate
quantitative results compared to imaging-based systems, which only examine up
to two parameters, are time-consuming and ultimately provide less quantitative
data. The system is capable of analyzing both suspension and adherent cells
from two to sixty μm in diameter. Intuitive software and simple touchscreen
interface enable rapid set-up and analysis. The system is complemented by
all-in-one kits for cell count and viability, apoptosis and cell cycle. They
come with all the reagents necessary for proper sample preparation.

For 2012, the Museum received submissions from several thousand of the world’s
leading manufacturers and industrial and graphic design firms from around the
world representing the most important and critical mass of influential
corporations worldwide in the design industry from over 48 countries.

The jury selected over 700 product designs and graphics from over 38 nations
worth of the GOOD DESIGN® Award for their design excellence.

Other GOOD DESIGN® 2012 winners in the medical product category include: GE
Healthcare, Ltd, Novo Nordisk A/S, and Sanofi-Aventis Deutschland GmbH.

About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers
a broad range of innovative, performance products, services and business
relationships that enable our customers' success in research, development and
production of biotech and pharmaceutical drug therapies. Through dedicated
collaboration on new scientific and engineering insights, and as one of the
top three R&D investors in the Life Science Tools industry, EMD Millipore
serves as a strategic partner to customers and helps advance the promise of
life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000
employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion.
EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany

About Merck
All Merck Press Releases are distributed by e-mail at the same time they
become available on the Merck Website. Please go to
http://www.merck.de/subscribe to register online, change your selection or
discontinue this service.

Merck is a global pharmaceutical and chemical company with total revenues of €
10.3 billion in 2011, a history that began in 1668, and a future shaped by
more than 40,000 employees in 67 countries. Its success is characterized by
innovations from entrepreneurial employees. Merck's operating activities come
under the umbrella of Merck KGaA, in which the Merck family holds an
approximately 70% interest and shareholders own the remaining approximately
30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an
independent company ever since.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130228005127/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50579266&lang=en

Contact:

For EMD Millipore
Jennifer Bianco, + 1 978-715-1594
Jennifer.Bianco@merckgroup.com